Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
09 September 2019 | Story Valentino Ndaba | Photo Charl Devenish
Silent march
Students and staff marched in solidarity with other South African universities against gender-based violence.

“Now is a time for us as men to say from the bottom of our hearts that indeed we are ashamed. Not only are we ashamed, we will speak and act against any form of violence. The very same people you see here are the very same people we need to protect, and if we do not protect them then we are rotten fruits,” said Katleho Lechoo, President of the Student Representative Council (SRC) at a silent march against gender-based violence held on the Bloemfontein Campus.

On Friday 6 September 2019, the University of the Free State (UFS) executive management and the SRC suspended all academic activities on its three campuses as a gesture of solidarity with the national movement opposing the rape, murder, and abuse of women across the country. A prayer service was also held on the Qwaqwa Campus. The UFS community came out in numbers to mourn victims and stand in support with survivors and those affected by gender-based violence

Remembering Uyinene, Jesse, and many others
Prof Francis Petersen, UFS Rector and Vice-Chancellor, said the recent rape and murder of 19-year-old Media and Film Studies student at the University of Cape Town (UCT), Uyinene Mrwetyana, and the murder of University of Western Cape (UWC) student, Jesse Hess, are painful reminders of the pervasive nature of misogyny and patriarchal violence that impedes the freedom of women in South Africa. “The UFS stands in solidarity with UCT and UWC and all other SA universities that are currently steeped in this national crisis,” he said.

Prof Petersen then called on the Department of Higher Education, civil society, the business sector, and all other roleplayers to actively contribute to efforts to eradicate gender violence. “As a university, we call specifically on the city of Bloemfontein, the mayor, members of local government, the South Africa Police Service and all inhabitants to assist us in making our city safe.”

Reading from the statement of commitment declaring the position of the UFS, Prof Petersen said: “In light of the ongoing violence against women and the recent surge of femicide in SA, the UFS commits itself to challenge, fight, and eradicate all forms of gender-based violence on its campuses and in our country.”

Cry our beloved country
At the end of the proceedings, Prof Puleng LenkaBula called for change, following emotive addresses by student leaders. “The poem and the speeches that have been made are demonstrative of the woundedness of our hearts, of our souls, of our bodies, and the fact that women’s bodies have been made a battleground. Therefore as a university it is important that we recommit ourselves to ensuring that our legs and our thighs do not define us but who we are as human beings is respected,” said the Vice-Rector: Institutional Change, Student Affairs, and Community Engagement.

“Enough is enough!”

Related:


University of the Free State's position on Gender-Based violence




News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept